Archive

Real world evidence from Peru and Colombia confirms ivermectin safe and effective

Written by | 27 Mar 2021

The real world evidence about ivermectin combined with the findings from meta-analyses of clinical trials provide compelling evidence for the safety and effectiveness of ivermectin, according to Dr […]

Colombian ivermectin study – how protocol violations influenced results

Written by | 26 Mar 2021

The results of the recent controlled trial of ivermectin for covid-19 in Colombia suggest that both ivermectin and control groups received ivermectin, according to Dr David Scheim. The […]

Protocol violations in Colombian ivermectin study compromise results

Written by | 25 Mar 2021

Dr David Scheim explains how multiple protocol violations and widespread use of over-the-counter ivermectin could have compromised the results of a recent controlled trial of ivermectin for covid-19 […]

Ivermectin in Peru – results that save lives

Written by | 24 Mar 2021

Dr David Scheim explains how the original analysis factored out confounders and showed a 74% reduction in deaths at 30 days as a result of intensive ivermectin distribution. […]

Analysis confirms 14 fold reduction in deaths with Ivermectin treatment in Peru

Written by | 23 Mar 2021

Further analysis of results from Peru has now shown that systematic treatment of the population for covid-19 with ivermectin resulted in a 14-fold reduction in excess deaths. IMI interviewed Dr […]

Ivermectin mass treatment in perspective

Written by | 17 Feb 2021

Ivermectin is a good treatment to use interim to and complementary to immunisations, according to Dr David Scheim, one of the authors of a study of mass treatment for covid-19 […]

Ivermectin dosing and distribution for mass treatment

Written by | 16 Feb 2021

Dr David Scheim, one of the authors of a recent study in Peru, describes the doses of ivermectin that were used and the strategies for effective mass distribution. The […]

Ivermectin gathers pace in Europe

Written by | 31 Jan 2021

During the past week Slovakia became the first European country to give formal approval for the use of ivermectin for both prophylaxis and treatment of covid-19 patients. Ivermectin […]

Ivermectin meta-analysis – the implications

Written by | 27 Jan 2021

Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, describes the implications of her recently-published meta-analysis of ivermectin trials for covid-19. Dr Lawrie is now trying to make an […]

Ivermectin meta-analysis – the findings

Written by | 26 Jan 2021

Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, describes the key findings from her recently-published meta-analysis of ivermectin trials for covid-19. The first finding was that ivermectin […]

Ivermectin meta-analysis – the background

Written by | 25 Jan 2021

IMI interviewed Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, to find out more about her recently-published meta-analysis of ivermectin trials for covid-19. The Evidence-based Medicine Consultancy […]

Ivermectin for covid-19 – 56 RCTs so far

Written by | 30 Dec 2020

A meta-analysis of 11 randomised clinical trials of ivermectin to treat covid-19 infection shows a resoundingly positive effect. In summary, ivermectin treatment is associated with: Faster viral clearance Shorter duration […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.